Content about Viruses

February 24, 2014

Hyland's recently added three line extensions to its portfolio of cough-cold products — both an adult and pediatric mucus expectorant and a nighttime option for toddlers.

LOS ANGELES — Hyland's recently added three line extensions to its portfolio of cough-cold products — both an adult and pediatric mucus expectorant and a nighttime option for toddlers. Mucus relief accounts for 14% of the cough-cold category, Hyland's reported, citing Nielsen data for the 52 weeks ended Jan. 18 across all channels. 

December 13, 2013

According to published reports, Express Scripts may be looking to start a "price war" among the makers of the latest generation of drugs for hepatitis C — which promise much shorter treatment times than standard therapies, but also cost significantly more — in an effort to bring down prices.

The stakes are certainly high. According to Centers for Disease Control and Prevention, there are 3.2 million people in the United States chronically infected with hepatitis C and hence at risk for liver cancer, and the CDC recommends that anyone born between 1945 and 1965 get tested for the virus.

According to published reports, Express Scripts may be looking to start a "price war" among the makers of the latest generation of drugs for hepatitis C — which promise much shorter treatment times than standard therapies, but also cost significantly more — in an effort to bring down prices.

November 11, 2013

The voluntary action taken five years ago by manufacturers of cough and cold medicines — namely to no longer recommend the use of OTC cough-cold products in children under the age of 4 years unless directed to do so by a doctor — has worked, according to a study published Monday online by Pediatrics, the peer-reviewed journal of the American Academy of Pediatrics.

BURLINGTON, Vt. — The voluntary action taken five years ago by manufacturers of cough and cold medicines — namely to no longer recommend the use of OTC cough-cold products in children under the age of 4 years unless directed to do so by a doctor — has worked, according to a study published Monday online by Pediatrics, the peer-reviewed journal of the American Academy of Pediatrics. 

March 21, 2013

Norovirus has emerged as the leading cause of gastroenteritis - inflammation of the stomach and intestines - in children younger than 5 years, according to a new study.

ATLANTA — Norovirus has emerged as the leading cause of gastroenteritis — inflammation of the stomach and intestines — in children younger than 5 years, according to a new study.

March 7, 2013

Heel on Thursday announced the launch of the Reboost cold and flu product line and new packaging for the Traumeel pain relief product line.

ALBUQUERQUE, N.M. — Heel on Thursday announced the launch of the Reboost cold and flu product line and new packaging for the Traumeel pain relief product line. The Reboost product line brings together four of the company’s cold, cough and flu products under a single brand that has been specifically designed to speak to the consumer in a retail environment. 

January 24, 2013

A new strain of norovirus from Australia accounts for more than half of outbreaks around the country, according to the Centers for Disease Control and Prevention.

NEW YORK — A new strain of norovirus from Australia accounts for more than half of outbreaks around the country, according to the Centers for Disease Control and Prevention.

October 27, 2011

An experimental vaccine for hepatitis B made by Dynavax Technologies appears to work better in patients with diabetes than current treatments, the company said.

BERKELEY, Calif. — An experimental vaccine for hepatitis B made by Dynavax Technologies appears to work better in patients with diabetes than current treatments, the company said.

July 28, 2011

The Hepatitis Education Awareness and Liver Support of the South is advocating for awareness about hepatitis and the importance of Medicare Part D as part of World Hepatitis Day, the organization said Thursday.

TALLAHASSEE, Fla. — The Hepatitis Education Awareness and Liver Support of the South is advocating for awareness about hepatitis and the importance of Medicare Part D as part of World Hepatitis Day, the organization said Thursday.

July 12, 2011

The Food and Drug Administration has granted orphan drug designation to a cancer treatment in mid-stage development made by German drug maker 4SC, the company said Tuesday.

PLANEGG-MARTINSRIED, Germany — The Food and Drug Administration has granted orphan drug designation to a cancer treatment in mid-stage development made by German drug maker 4SC, the company said Tuesday.

4SC announced that it received the designation for resminostat, currently in phase-2 clinical trials as a treatment for hepatocellular cancer, or HCC. The FDA grants orphan drug designation to drugs for diseases that affect fewer than 200,000 people in the United States.

May 9, 2011

Drug maker Merck announced that it has kicked off an initiative that includes a wide range of public education and patient support programs, as well as research efforts to help improve care for people living with chronic hepatitis C virus infections.

WHITEHOUSE STATION, N.J. — Drug maker Merck announced that it has kicked off an initiative that includes a wide range of public education and patient support programs, as well as research efforts to help improve care for people living with chronic hepatitis C virus infections.

Merck's Hope Against Hepatitis C initiative includes a variety of public-private partnerships, educational programs and collaborative research efforts aimed at supporting the hepatitis C community.

April 21, 2011

Merck and Sanofi Pasteur have started a late-stage clinical trial of a combination vaccine for six childhood diseases, the companies said Thursday.

WHITEHOUSE STATION, N.J. — Merck and Sanofi Pasteur have started a late-stage clinical trial of a combination vaccine for six childhood diseases, the companies said Thursday.

February 18, 2011

NEW YORK — The second half of the 2010-2011 cough-cold-flu season actually may realize greater sales of symptom relievers than last year, judging from the four weeks ended Dec. 26. According to Matrixx president and CEO Bill Hemelt, sales of remedies were on the rise in those four weeks. Hemelt noted that the total cough-cold category was 5% higher than the same period last year and growing. 


January 12, 2011

Puffs, a Procter & Gamble brand, recently brought spokeswoman Tanya Remer Altmann to share tips with mommy bloggers and their children on healthy winter habits.

NEW YORK — Puffs, a Procter & Gamble brand, recently brought spokeswoman Tanya Remer Altmann to share tips with mommy bloggers and their children on healthy winter habits.

Altmann, a UCLA-trained pediatrician, visited New York City indoor child play space Apple Seeds to give out samples of Puffs tissues and to educate children on good hand-washing habits, best tissues to use for those with sore and chapped noses and ways to avoid coughs, colds and flu during the winter.

December 15, 2010

Prestige Brands last month announced the introduction of Little Colds Honey Elixir, a nonmedicated treatment for cough and sore throat, as the newest addition to the Little Remedies line.

IRVINGTON, N.Y. — Prestige Brands last month announced the introduction of Little Colds Honey Elixir, a nonmedicated treatment for cough and sore throat, as the newest addition to the Little Remedies line.

“The incidence of cough is already higher this year than last [year] among children [under 5 years of age], according to the Fan Flu data reports in November,” stated Jean Boyko, SVP science and technology at Prestige.

October 25, 2010

Matrixx Initiatives on Monday reported a decline of 17% in net sales to $21.3 million...

SCOTTSDALE, Ariz. Matrixx Initiatives on Monday reported a decline of 17% in net sales to $21.3 million for the company’s second quarter ended Sept. 30. The decline, Matrixx president and CEO Bill Hemelt explained to analysts Tuesday morning, represented a course correction of sorts. The sales decline was “due to lower upfront buys by retailers,” Hemelt said. Last year, all of the hype around H1N1 drove retailers to heavily stock in cough-and-cold supplies.

October 18, 2010

A new national survey of U.S. adults has found the majority of Americans are misinformed...

October 17, 2010

The Food and Drug Administration has approved an additional use for a hepatitis drug....

PRINCETON, N.J. The Food and Drug Administration has approved an additional use for a hepatitis drug.

 

Bristol-Myers Squibb announced Monday the approval of Baraclude (entecavir) as a treatment for chronic hepatitis B in adults with decompensated liver disease. The drug already is approved for adults with evidence of active viral replication.

 

 

September 26, 2010

A study sponsored by Kaz, the manufacturer of Vicks humidifiers, found that such devices as...

LONDON and BOSTON A study sponsored by Kaz, the manufacturer of Vicks humidifiers, found that such devices as humidifiers may play a role in reducing airborne flu viruses in the home.

August 24, 2010

Joining parents this fall in the fight against kids’ cough-cold and allergy symptoms are two...

WESTLAKE, Ohio Joining parents this fall in the fight against kids’ cough-cold and allergy symptoms are two new products from homeopathic-medicine provider Hyland’s: Nighttime Cold ’n Cough 4 Kids and Complete Allergy 4 Kids.

WESTLAKE, Ohio Joining parents this fall in the fight against kids’ cough-cold and allergy symptoms are two new products from homeopathic-medicine provider Hyland’s: Nighttime Cold ’n Cough 4 Kids and Complete Allergy 4 Kids.

May 13, 2010

It is “appropriate” for healthcare professionals to continue use of GlaxoSmithKline’s rotavirus vaccine Rotarix and...

May 10, 2010

The benefits of vaccinating babies against rotavirus outweigh the theoretical risks of porcine circovirus found...

March 21, 2010

The Food and Drug Administration has asked healthcare professionals to temporarily stop using a vaccine...

March 18, 2010

“Systemic underfunding” at the Centers for Disease Control and Prevention’s Division of Viral Hepatitis puts...

WASHINGTON “Systemic underfunding” at the Centers for Disease Control and Prevention’s Division of Viral Hepatitis puts the health of millions of Americans with viral hepatitis at risk, a group of organizations focused on the disease said this week.

January 10, 2010

The independent nonprofit partner of the Centers for Disease Control and Prevention and the CDC's...